Jane Street’s Psyence Biomedical PBM Stock Holding History

Jane Street’s Portfolio PBM Stock Details PBM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$93.1K	Buy	+30,431	New	+$138K	﹤0.01%	10635
2024 Q4	–	Sell	-12	Closed	-$4.6K	–	10785
2024 Q3	$4.6K	Buy	+12	New	+$16.2K	﹤0.01%	9408

Other funds holding PBM

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

SFFS

Stonehage Fleming Financial Services St. Helier, Jersey $2.93B AUM 16.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Caitlin John Brighton, Michigan $183M AUM 30.77% 1-Year Est. Return

Jane Street's PBM Position: Q2 2026 in Review

Jane Street opened a new position in Psyence Biomedical (PBM) in Q2 2026: 30,431 shares worth $93.1K. The stake represents ﹤0.01% of the portfolio and ranks #10635 among its holdings. This is a return to the name: Jane Street previously reported a position in PBM as recently as Q3 2024.

Jane Street first reported a position in PBM in Q3 2024 and has held it in 2 quarters since. 9 funds tracked by Wall St. Rank hold PBM as of Q2 2026.

Jane Street held 30,431 shares of Psyence Biomedical worth $93.1K as of Q2 2026.
Psyence Biomedical was a new Jane Street position in Q2 2026.
Psyence Biomedical made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10635 holding.
Jane Street first reported a position in Psyence Biomedical in Q3 2024 and has held it in 2 quarters since.
9 funds tracked by Wall St. Rank held Psyence Biomedical as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.